Navigation Links
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
Date:10/28/2011

ty in (earnings)/losses of equity method investees (0.8) 0.3 (3.2) (0.2) Changes in operating assets and liabilities: Increase in accounts receivable (66.7) (94.1) (122.8) (138.0) (Decrease)/increase in sales deduction accrual (19.9) 14.8 46.2 169.0 Increase in inventory (12.2) (4.1) (42.8) (54.1) Decrease/(increase) in prepayments and other assets 31.1 16.2 17.3 (67.0) (Decrease)/increase in accounts payable and other liabilities (24.3) 2.3 (101.4) (41.0) Returns on investment from joint venture 5.2 5.8 5.2 5.8 Net cash provided by operating activities(A) 178.7 142.0 664.2 612.0

Unaudited US GAAP results for the three months and nine months to September 30, 2011
Consolidated Statements of Cash Flows (continued)

3 months to September 9 months to September 30, 30, 2011 2010 2011 2010 $M $M $M $M CASH FLOWS FROM INVESTING ACTIVITIES: Movements in restricted cash 0.9 (553.0) 5.7 (547.0) Purchases of subsidiary undertakings, net of cash acquired (3.8) - (723.5) - Payments on foreign exchange contracts related to Movetis - (21.2) - (21.2) Purchases of non-current investments (3.8) (1.0) (8.3) (1.0) Purchases of property, plant and equipment ("PP&E") (40.9) (53.5) (135.9) (261.7) Purchases of intangible assets (5.2) - (5.2) (2.7) Proceeds from disposal of non-current investments and PP&E 94.7 - 94.7 2.1 Proceeds/deposits received on sales of product rights 1.9 - 8.8 - Returns of equity investments and proceeds from short term investments 0.1 - 1.7 - Net cash provided by/(used in) investing activities(B) 43.9 (628.7) (762.0) (831.5) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from drawing of revolving credit facility - - 30.0 - Repayment of revolving credit facility (30.0) - (30.0) - Repayment of debt acquired with ABH - - (13.1) - Payment under building finance obligation (0.6) (0.4) (1.0) (1.8) Extinguishment of building finance obligation - - - (43.1) Tax benefit of stock based compensat
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Faced with increasing ... are palliative rather than symptomatic, the global healthcare ... existing therapies capable of curing or significantly changing ... starting to look towards regenerative medicine as a ... new paradigm in human health with the potential ...
(Date:7/27/2015)... ... July 27, 2015 , ... Production of high tenacity ... past few years in the EU. For instance, it surpassed the EUR 106 million ... million mark in 2010. Germany is a major producer, while Italy is a key ...
(Date:7/27/2015)... , July 27, 2015 According ... by Type (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative ... , Europe , Asia-Pacific ... 2019", The global biopreservation media market was valued at $247.7 ... $571.5 million by 2019, at a CAGR of 18.2% between ...
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards Company, LLC ... linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin B12 ... the CLSI recommended “equal delta” method for linearity testing and is liquid, ready-to-use. ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2
... SAN DIEGO, March 30 BrainCells Inc. (BCI), ... using its proprietary platform technology to identify novel ... today the appointment of Dr. Philip Jochelson as ... business officer. Both have extensive experience in the ...
... informed consent software for clinical research trials has named Jovianna ... over 20 years experience driving new pharmaceutical therapeutics and devices ... clinical development to commercialization. , ... ...
... ITMN ) today announced that Daniel G. Welch, ... at Citi,s 4th Annual Biotech Day in New York City ... access a live audio webcast of the presentation, investors and ... page of InterMune,s corporate website at www.intermune.com . ...
Cached Biology Technology:BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer 2BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer 3Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer 2
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
(Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... BOZEMAN Two Montana state University researchers are principal ... find noninvasive ways to study carnivores in the wild. ... was released June 27 with Robert Long and Paula ... at MSU,s Western Transportation Institute. Working with ...
... has shown that enhancing the production of a protein ... neuron death associated with Alzheimer,s, at the expense of ... amyloid-beta protein plaques within the brain is a major ... contribute to disease progression. Normally, special enzymes chew up ...
... type of probe that can image thousands of interactions ... tool to untangle the web of signaling pathways that ... use this to identify new protein partners or to ... the proteins are involved in and during which phase ...
Cached Biology News:
... now entered the next frontier of cell-based ... with Cellomics, Inc. The drug discovery process ... Coulter‘s automated solutions systems and Cellomics‘ HCS ... the sub-cellular level. The integration of these ...
... in conjunction with the EasyCount System to count ... ViaSure Staining Reagent uses a mixture of ready-to-use ... Bromide to identify live and dead cells, respectively, ... 6 Multi-well Slide provides the ability to ...
... laser scanners is the starting point of ... ,Gene expression analysis, SNP (Single Nucleotide Polymorphism) ... the advancement of research in the post-genomics ... formats and sizes. These arrays call for ...
... This kit allows for rapid, convenient, ... The simple bind/wash/elute process utilizes a spin ... uses beads for concentration of proteins which ... beads are strong ion exchangers, offering high ...
Biology Products: